claim: covid-19 vaccines that reduce symptoms but do can block infection need higher coverage and faster rollout to achieve population impact
evidence_1: the use of a symptom reducing vaccine will require twice as many people vaccinated than a susceptibility reducing vaccine with the same 90% vedis to prevent 50% of the infections and death over one year.